Literature DB >> 10981758

Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery.

P Reinstrup1, N Ståhl, P Mellergård, T Uski, U Ungerstedt, C H Nordström.   

Abstract

OBJECTIVE: The study was undertaken to measure baseline values for chemical markers in human subjects during wakefulness, anesthesia, and neurosurgery, using intracerebral microdialysis.
METHODS: Microdialysis catheters were inserted into normal posterior frontal cerebral cortex in nine patients who were undergoing surgery to treat benign lesions of the posterior fossa. The perfusion rate was 1.0 microl/min during anesthesia/neurosurgery and the early postoperative course and 0.3 microl/min during the later course. Bedside biochemical analyses of glucose, pyruvate, lactate, glycerol, glutamate, and urea were performed before, during, and after neurosurgery. After the bedside analyses, all samples were frozen for subsequent high-performance liquid chromatographic analyses of amino acids.
RESULTS: The following baseline values were obtained during wakefulness (perfusion rate, 0.3 microl/min): glucose, 1.7+/-0.9 mmol/L; lactate, 2.9+/-0.9 mmol/L; pyruvate, 166+/-47 micromol/L; lactate/pyruvate ratio, 23+/-4; glycerol, 82+/-44 micromol/L; glutamate, 16+/-16 mmol/L; urea, 4.4+/-1.7 mmol/L. Marked increases in the levels of all chemical markers were observed at the beginning and end of anesthesia/surgery.
CONCLUSION: The study provides human baseline levels for biochemical markers that can presently be measured at the bedside during neurointensive care. In addition, some changes that occurred under varying physiological conditions are described.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981758     DOI: 10.1097/00006123-200009000-00035

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  100 in total

1.  Comment on "Changes in cerebral interstitial glycerol concentration in head injured patients; correlation with secondary events".

Authors:  Carl-Henrik Nordström
Journal:  Intensive Care Med       Date:  2003-12-06       Impact factor: 17.440

Review 2.  Update on multimodality monitoring.

Authors:  Chad M Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

3.  Brain tissue oxygenation and cerebral perfusion pressure thresholds of ischemia in a standardized pig brain death model.

Authors:  Karlis Purins; Per Enblad; Lars Wiklund; Anders Lewén
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

Review 4.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

Review 5.  Physiological and biochemical principles underlying volume-targeted therapy--the "Lund concept".

Authors:  Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

6.  Brain energy metabolism and intracranial pressure in idiopathic adult hydrocephalus syndrome.

Authors:  A Agren-Wilsson; A Eklund; L-O D Koskinen; A T Bergenheim; J Malm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

7.  Cardiac biochemical monitoring for the detection of acute myocardial ischemia.

Authors:  Jochen Pöling; Wolfgang Rees; Stephan Klaus; Ludger Bahlmann; Mahesh Gumniah; Virgilius Ziaukas; Henning Warnecke
Journal:  Intensive Care Med       Date:  2006-03-02       Impact factor: 17.440

Review 8.  Physiological monitoring of the severe traumatic brain injury patient in the intensive care unit.

Authors:  Peter Le Roux
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

Review 9.  Changes in cerebral oxidative metabolism in patients with acute liver failure.

Authors:  P N Bjerring; F S Larsen
Journal:  Metab Brain Dis       Date:  2012-10-26       Impact factor: 3.584

Review 10.  Cerebral Microdialysis in Neurocritical Care.

Authors:  Ting Zhou; Atul Kalanuria
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-23       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.